- English , Health , Press Release
- April 29, 2021
- 331 views
ISSAR Pharma Announces Out-Licensing of Its Peptide-Based NCEs
ISSAR Pharma, the only company in India which focuses on the research and development of New Chemical Entities (NCE), is licensing out its NCEs based on peptide technology, opening opportunities…
